Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meningococcal C vaccine in children
NCT00310635Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Meningococcal group C polysaccharide conjugate vaccine in meningococcal infection, sponsored by Novartis. Started Jun 2005; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00310635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310635.